TY - JOUR
T1 - Primary focal prostate radiotherapy
T2 - Do all patients really need whole-prostate irradiation?
AU - Jereczek-Fossa, Barbara Alicja
AU - Ciardo, Delia
AU - Petralia, Giuseppe
AU - Bellomi, Massimo
AU - De Bari, Berardino
AU - De Cobelli, Ottavio
AU - Orecchia, Roberto
PY - 2015/11/9
Y1 - 2015/11/9
N2 - Objectives: To review the available data about focal primary partial prostate irradiation (focal radiotherapy, FRT) for early prostate cancer. Methods: Inclusion criteria: Medline search for English language full paper on primary FRT for early prostate cancer including review articles, planning studies or patient series (clinical outcome available) published before May 31, 2015. Results: 22 papers have been found: 11 review articles, 4 planning studies and 7 patient series. Eleven review articles were dedicated to all types of focal therapy including FRT and 2 to FRT only. All planning studies included brachytherapy and showed excellent organ-at-risk sparing. Patient series included together 715 patients (99% treated with brachytherapy) and showed promising tumour control in low-risk cancer. In intermediate-risk tumours, FRT might be suboptimal. Conclusions: Primary FRT is feasible in early prostate cancer. As any other focal therapy, FRT remains investigational until numerous questions are answered.
AB - Objectives: To review the available data about focal primary partial prostate irradiation (focal radiotherapy, FRT) for early prostate cancer. Methods: Inclusion criteria: Medline search for English language full paper on primary FRT for early prostate cancer including review articles, planning studies or patient series (clinical outcome available) published before May 31, 2015. Results: 22 papers have been found: 11 review articles, 4 planning studies and 7 patient series. Eleven review articles were dedicated to all types of focal therapy including FRT and 2 to FRT only. All planning studies included brachytherapy and showed excellent organ-at-risk sparing. Patient series included together 715 patients (99% treated with brachytherapy) and showed promising tumour control in low-risk cancer. In intermediate-risk tumours, FRT might be suboptimal. Conclusions: Primary FRT is feasible in early prostate cancer. As any other focal therapy, FRT remains investigational until numerous questions are answered.
KW - Focal radiotherapy
KW - Focal therapy
KW - Index lesion
KW - Intraprostatic lesion
KW - Primary partial prostate irradiation
UR - http://www.scopus.com/inward/record.url?scp=85003674259&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85003674259&partnerID=8YFLogxK
U2 - 10.1016/j.critrevonc.2016.06.010
DO - 10.1016/j.critrevonc.2016.06.010
M3 - Article
AN - SCOPUS:85003674259
SN - 1040-8428
JO - Critical Reviews in Oncology/Hematology
JF - Critical Reviews in Oncology/Hematology
ER -